ISM_MSBV_EARLY REDEMPTION_11-02-2026

Summary by AI ^BETAClose X

Morgan Stanley B.V. has announced early redemptions for several securities with various settlement dates in February 2026. Specifically, ISIN XS3211584803 and XS3211697910 are set for redemption on February 17th and February 18th respectively, each with an amount of 200,000. ISIN XS2893999842 will be redeemed on February 24th with an amount of 500,000. Additionally, ISINs XS3242775529, XS3242842659, and XS3242812744 are all scheduled for redemption on February 17th, each with an amount of 4,565,000. ISIN XS2862263378 will be redeemed on February 16th with an amount of 250,000, and ISIN XS3211700722 will be redeemed on February 18th with an amount of 250,000.

Disclaimer*

Morgan Stanley B.V.

11 February 2026

Morgan Stanley & Co. International plc

25 Cabot Square

Canary Wharf

E14 4QA

11 February 2026

Early Redemption Notification

Dear All,

Please note that there has been an Early Redemption for the following ISIN(s)/CUSIP(s):

ISIN(s)	Issuer	Amount	Settlement Date
XS3211584803	MORGAN STANLEY B.V.	200,000	17-Feb-26
XS2893999842	MORGAN STANLEY B.V.	500,000	24-Feb-26
XS3242775529	MORGAN STANLEY B.V.	4,565,000	17-Feb-26
XS3242842659	MORGAN STANLEY B.V.	4,565,000	17-Feb-26
XS3242812744	MORGAN STANLEY B.V.	4,565,000	17-Feb-26
XS2862263378	MORGAN STANLEY B.V.	250,000	16-Feb-26
XS3211697910	MORGAN STANLEY B.V.	200,000	18-Feb-26
XS3211700722	MORGAN STANLEY B.V.	250,000	18-Feb-26

Please do not hesitate to contact us for further information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END